In the biomedical field, glyconanoparticles are highly sought after for their unique biocompatibility, targeting, and drug-delivery capabilities. CD BioGlyco provides reliable Glyconanoparticle Development, Characterization, and Preclinical Study services. We provide pharmacokinetic study services for glyconanoparticles to gain an in-depth understanding of their behavior in vivo and in vitro, including key processes such as absorption, distribution, metabolism, excretion, and half-life.
Pharmacokinetics is the science of quantitatively studying the dynamics of drug absorption, distribution, metabolism, and excretion in living organisms, and elucidating the relationship between drug concentration at different sites and time. We have abundant In Vitro Models and In Vivo Models for glyconanoparticle pharmacokinetic studies.
Our company evaluates the absorption efficiency of glyconanoparticles in different tissues or organs by simulating physiological conditions, providing data support for the optimization of the drug delivery system.
Our company utilizes advanced imaging techniques and bioanalytical methods to track the distribution pathways of glyconanoparticles, revealing their targeting and tissue penetration capabilities.
Metabolism Study
Our company provides services to analyze the metabolic pathways and metabolites of glyconanoparticles in living organisms, and to assess their effects and potential toxicity on biological systems.
Excretion Study
Our company provides excretion monitoring services for glyconanoparticles, including urinary, fecal, and other excretion routes, to provide support for drug safety and pharmacokinetic parameters.
Half-life Study
Our company determines the half-life of glyconanoparticles by monitoring their concentration in the body over time, which is critical for evaluating drug duration and dose design.
We have an experienced research team and a specialized GlycoNano™ Platform with powerful testing and analysis capabilities to perform a wide range of flexible tests. Specific services include the following:

Technology: Fourier transform infrared (FTIR) spectra, Nuclear magnetic resonance (NMR), Transmission electron microscope (TEM), High-performance liquid chromatography (HPLC)
Journal: Pharmaceutics
Published: 2022
IF: 4.9
Results: In this study, glucose-modified zein (GZ) nanoparticles loaded with docetaxel (DTX) (DTX-GNPs) were prepared, characterized, and evaluated in vitro and in vivo for cellular uptake, absorption sites, pharmacokinetics, in vitro distribution, and antitumor effects. Glucose modification significantly enhanced the absorption of DTX-NPs in the jejunum and ileum. The enhanced tumor targeting of GZ-NPs is related to their particle size, surface charge, and glucose modifications.GZ-NPs reduced the toxicity of docetaxel in the liver, kidney, and lung and improved its safety.
Fig.1 Studies on the cellular uptake mechanism of DTX nanoparticles. (Xing, et al., 2022)
Based on a high-quality GlycoNano™ platform, CD BioGlyco provides professional glyconanoparticle pharmacokinetic study services including absorption, distribution, metabolism, excretion, and half-life studies. If you are interested in our preclinical studies, please feel free to contact us.
Reference
About Us
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.